PMID: 16531923Mar 15, 2006Paper

Effect of a 188 Re-SSS lipiodol/131I-lipiodol mixture, 188 Re-SSS lipiodol alone or 131I-lipiodol alone on the survival of rats with hepatocellular carcinoma

Nuclear Medicine Communications
Elienne GarinJean-Jacques Lejeune

Abstract

It has been shown that the use of a cocktail of isotopes of different ranges of action leads to an increase in the effectiveness of metabolic radiotherapy. The purpose of the present study was to compare with a control group the effectiveness of three different treatments in rats bearing hepatocellular carcinoma (HCC), using (1) a mixture of lipiodol labelled with both I and Re, (2) lipiodol labelled with I alone and (3) lipiodol labelled with Re alone. Four groups were made up, each containing 14 rats with the N1-S1 tumour cell line. Group 1 received a mixture composed of 22 MBq of Re-SSS lipiodol and 7 MBq I-lipiodol. Group 2 received 14 MBq I-lipiodol. Group 3 received 44 MBq of Re-SSS lipiodol and group 4 acted as the control. The survival of the various groups was compared by a non-parametric test of log-rank, after a follow-up of 60, 180 and 273 days. Compared with the controls, the rats treated with a mixture of Re-SSS lipiodol and I-lipiodol show an increase in survival, but only from day 60 onwards (P=0.05 at day 60 and 0.13 at days 180 and 273). For the rats treated with I-lipiodol, there was a highly significant increase in survival compared with the controls at day 60, day 180 and day 273 (P=0.03, 0.04 and 0.04, res...Continue Reading

Associated Clinical Trials

References

Jun 1, 1991·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·T E WheldonA S Michalowski
Jan 1, 1989·Cancer Chemotherapy and Pharmacology·H S YooM T Madsen
Aug 1, 1988·European Journal of Cancer & Clinical Oncology·M A BurtonA Coletti
Jan 1, 1996·European Journal of Nuclear Medicine·S J WangF F Knapp
Apr 17, 1998·Histopathology·J KaczynskiS Wallerstedt
May 15, 1998·Digestive Diseases and Sciences·R Gómez SanzI Gonzalez-Pinto
Oct 13, 1999·Seminars in Liver Disease·F X BoschJ Borràs
Apr 11, 2001·Nuclear Medicine and Biology·J M JeongM C Lee
Jul 12, 2002·European Journal of Nuclear Medicine and Molecular Imaging·B BransR A Dierckx
Dec 24, 2003·European Journal of Nuclear Medicine and Molecular Imaging·E GarinP Bourguet
Oct 7, 2004·Journal of Vascular and Interventional Radiology : JVIR·Chang Jin YoonJin Chul Paeng
Jun 11, 2005·Journal of Vascular and Interventional Radiology : JVIR·Etienne GarinJean-Jacques Lejeune

❮ Previous
Next ❯

Citations

Apr 21, 2012·International Journal of Molecular Imaging·Nicolas LepareurEtienne Garin
May 2, 2008·American Journal of Veterinary Research·Lauren G KleineCarl A Kirker-Head

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.